Open AccessOutcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure
Author(s) -
Adnan I. Qureshi,
Wei Huang,
Iryna Lobanova,
William G. Barsan,
Daniel F. Hanley,
Chung Y. Hsu,
ChengLi Lin,
Robert Silbergleit,
Thorsten Steiner,
José I. Suárez,
Ḱazunori Toyoda,
Haruko Yamamoto,
for ATACH-II trial investigators
Publication year - 2020
Publication title -
jama neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.298
H-Index - 231
eISSN - 2168-6157
pISSN - 2168-6149
DOI - 10.1001/jamaneurol.2020.3075
Subject(s) - medicine , blood pressure , intracerebral hemorrhage , anesthesia , nicardipine , adverse effect , cardiology , randomized controlled trial , randomization , stroke (engine) , subarachnoid hemorrhage , engineering , mechanical engineering
The safety and efficacy of intensive systolic blood pressure reduction in patients with intracerebral hemorrhage who present with systolic blood pressure greater than 220 mm Hg appears to be unknown.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom